These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26954340)

  • 1. Characteristics and Public Availability of Results of Clinical Trials on Rare Diseases Registered at Clinicaltrials.gov.
    Dechartres A; Riveros C; Harroch M; Faber T; Ravaud P
    JAMA Intern Med; 2016 Apr; 176(4):556-8. PubMed ID: 26954340
    [No Abstract]   [Full Text] [Related]  

  • 2. Overview of registered studies in orthodontics: Evaluation of the ClinicalTrials.gov registry.
    Allareddy V; Rampa S; Masoud MI; Lee MK; Nalliah R; Allareddy V
    Am J Orthod Dentofacial Orthop; 2014 Nov; 146(5):587-93. PubMed ID: 25439209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
    Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
    JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of characteristics of registered studies on dental implants.
    Gajendrareddy P; Elangovan S; Rampa S; Allareddy V; Lee MK; Nalliah RP; Allareddy V
    J Evid Based Dent Pract; 2014 Sep; 14(3):111-7. PubMed ID: 25234209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ClinicalTrials.gov to estimate condition-specific nocebo effects and other factors affecting outcomes of analgesic trials.
    Cepeda MS; Lobanov V; Berlin JA
    J Pain; 2013 Apr; 14(4):405-11. PubMed ID: 23453563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Brazilian clinical studies registered in ClinicalTrials.gov between 2010 and 2020.
    Tiguman GMB
    J Evid Based Med; 2020 Nov; 13(4):261-264. PubMed ID: 33145995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Making available information from studies sponsored by the pharmaceutical industry: some current practices.
    O'Kelly M; Julious SA; Pyke S; Day S; Todd S; Seldrup J; Matcham J
    Pharm Stat; 2011; 10(1):60-9. PubMed ID: 21275036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 9. Registration of phase 3 crossover trials on ClinicalTrials.gov.
    Zeng L; Qureshi R; Viswanathan S; Drye L; Li T
    Trials; 2020 Jul; 21(1):613. PubMed ID: 32631413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Registering a clinical trial in ClinicalTrials.gov.
    Zarin DA; Keselman A
    Chest; 2007 Mar; 131(3):909-912. PubMed ID: 17303677
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-commercial vs. commercial clinical trials: a retrospective study of the applications submitted to a research ethics committee.
    Fuentes Camps I; Rodríguez A; Agustí A
    Br J Clin Pharmacol; 2018 Jun; 84(6):1384-1388. PubMed ID: 29446851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public availability of results of trials assessing cancer drugs in the United States.
    Nguyen TA; Dechartres A; Belgherbi S; Ravaud P
    J Clin Oncol; 2013 Aug; 31(24):2998-3003. PubMed ID: 23878298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes to registration elements and results in a cohort of Clinicaltrials.gov trials were not reflected in published articles.
    Pranić S; Marušić A
    J Clin Epidemiol; 2016 Feb; 70():26-37. PubMed ID: 26226103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to information supporting availability of medicines for patients suffering from rare diseases looking for possible treatments: the EuOrphan Service.
    Stakisaitis D; Spokiene I; Juskevicius J; Valuckas KP; Baiardi P
    Medicina (Kaunas); 2007; 43(6):441-6. PubMed ID: 17637514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of phase IV clinical trials for postmarket drug safety surveillance: a status report from the ClinicalTrials.gov registry.
    Zhang X; Zhang Y; Ye X; Guo X; Zhang T; He J
    BMJ Open; 2016 Nov; 6(11):e010643. PubMed ID: 27881517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blinded sample size reestimation in non-inferiority trials with binary endpoints.
    Friede T; Mitchell C; Müller-Velten G
    Biom J; 2007 Dec; 49(6):903-16. PubMed ID: 17726715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database.
    Subherwal S; Patel MR; Chiswell K; Tidemann-Miller BA; Jones WS; Conte MS; White CJ; Bhatt DL; Laird JR; Hiatt WR; Tasneem A; Califf RM
    Circulation; 2014 Nov; 130(20):1812-9. PubMed ID: 25239436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials registries: towards improved access to therapeutic data.
    Prescrire Int; 2008 Dec; 17(98):256-9. PubMed ID: 19425275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of randomized controlled trials.
    Stanley K
    Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574
    [No Abstract]   [Full Text] [Related]  

  • 20. Sharing of Data From Industry-Funded Registered Clinical Trials.
    Boutron I; Dechartres A; Baron G; Li J; Ravaud P
    JAMA; 2016 Jun; 315(24):2729-30. PubMed ID: 27367768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.